Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.
about
Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysisNovel Insights into Acid-Sensing Ion Channels: Implications for Degenerative DiseasesPaediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment ChoicesClinical perspectives of TRAIL: insights into central nervous system disordersExploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosisFriends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative DiseasesTreatment strategies for multiple sclerosis: When to start, when to change, when to stop?Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosisNeonatal inflammatory pain and systemic inflammatory responses as possible environmental factors in the development of autism spectrum disorder of juvenile rats.Tertiary Lymphoid Organs in Central Nervous System AutoimmunityNew Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple SclerosisPrecision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive AstrocytesInflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple SclerosisVitamin D Actions on CD4(+) T Cells in Autoimmune DiseaseNo quiet surrender: molecular guardians in multiple sclerosis brainMultiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem CellsThe Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment OptionsIron in multiple sclerosis: roles in neurodegeneration and repair.Use of natalizumab in multiple sclerosis: current perspectives.Progressive multiple sclerosis: from pathogenic mechanisms to treatment.Accelerated differentiation of human induced pluripotent stem cells to blood-brain barrier endothelial cells.Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration.Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortexAxonal degeneration in multiple sclerosis: can we predict and prevent permanent disability?Visual pathway neurodegeneration winged by mitochondrial dysfunction.Neurodegeneration in Autoimmune Optic Neuritis Is Associated with Altered APP Cleavage in Neurons and Up-Regulation of p53Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study.Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis.Dietary Interventions in Multiple Sclerosis: Development and Pilot-Testing of an Evidence Based Patient Education Program.Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunityExcitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis.Adipsin Is Associated with Multiple Sclerosis: A Follow-Up Study of Adipokines.Outer retinal changes following acute optic neuritis.Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression.Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory disease.Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life settingActivity of NaV1.2 promotes neurodegeneration in an animal model of multiple sclerosis.Analysis of ageing-associated grey matter volume in patients with multiple sclerosis shows excess atrophy in subcortical regions.NADPH oxidase in brain injury and neurodegenerative disordersPattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing-remitting MS
P2860
Q24185820-CDA4CC36-198E-425F-A109-C8BB781D7329Q26738902-1E50DB2C-09DA-42F2-853B-1F2767594F4DQ26748229-7D5B562E-A2C8-4530-89AF-486E7699D2BFQ26766570-7A99A0BE-B4F2-4B14-8DAE-F52062C5DF2BQ26770818-1495AAF8-BC4E-4167-B8CF-506B1B2244B4Q26779933-5BC4FFA0-3117-4A25-B2BD-2A2CAB9535E1Q26798434-3C82B5B2-6FA2-4031-95BD-CDB6D79D8C4AQ26827402-90C550A2-AC83-43DB-B4EC-91CC62557DBCQ27303121-72C682A7-D60C-4296-9A74-97C0D6AF9340Q28071379-55AFE51B-6358-45D0-8A55-B994D658CC86Q28072844-6771F9EF-E998-4096-95BC-C9F76D1B6D99Q28078621-8DCF326F-3928-48B7-AF60-CF2A0673FC43Q28080754-7BD87992-8915-4653-A767-9058392896EEQ28081150-A1FFA413-E5B4-4B20-9DB1-20E0B9657CEBQ28084633-DD19DC66-692A-430C-80C7-F1F5432AAA6FQ28551899-1BA048D5-4B96-45F4-B49B-5F3EEEA7F459Q28601505-82424EFA-773F-4CA2-9C58-226E6E07D953Q30835527-DB87A3D0-6CE8-4A4C-B314-20311EC7AB4FQ31114633-1EFE7B7F-5DA0-4643-9FCE-9433BB5D5D45Q31139925-6B327010-DB01-4B14-A107-4B01918A68B0Q33560284-BDE6FD69-CAD6-4334-803D-0FD2C0087EF8Q34463760-FB9E69F8-483E-48D9-ABB7-A34707F119D7Q34543420-DC1166F6-AAC9-4192-891D-43FE83F000B4Q34570124-621A1261-550C-41A8-8159-49792863C5D2Q35115909-A5FB735D-D223-4E3F-A05B-788169FCFE05Q35794898-5A210742-C4BC-4A6E-95DB-24F87FBC9591Q35853077-0E12918B-B8E3-4903-8467-4EB0731EE867Q36088247-ED7CF483-6312-46B3-9860-15D4DD8746ABQ36169584-0A3BA9F0-B77D-4180-A3A2-F3A37E43B741Q36278892-8B3BD482-192E-493B-AE59-D007AFDD537BQ36283207-BAAB011A-16E3-4A5D-B726-AAB614414A10Q36304666-7EBE13EF-69CF-4013-8672-1E90013DA30BQ36495226-782F5C0E-4E14-49A4-9171-13494E022B63Q36570149-C73643E9-CF1C-4996-A6F9-61EBCB18E204Q37080194-528EA39F-B470-4AD2-9B78-A6C7406C98CDQ37282063-B49A377B-E937-4A30-8077-4390D598AD8FQ37417523-DF27A7EF-C3C8-4FA0-A433-8F2F766DBB7AQ37433538-B281CAE8-7644-4812-8857-DBC360DBB678Q37589114-EEFB7682-DDA7-4B63-B54E-9EDACFD0A58CQ37653515-45B394E3-4C8A-4166-B4CE-738821BBD5F9
P2860
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.
@en
type
label
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.
@en
prefLabel
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.
@en
P2860
P356
P1476
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
@en
P2093
Benjamin Schattling
Lars Fugger
P2860
P2888
P304
P356
10.1038/NRNEUROL.2014.37
P407
P577
2014-03-18T00:00:00Z
P6179
1014362123